Key Stats for ASML Stock
- 52-Week Range: $631 to $1,547
- Current Price: $1,450
- Street Mean Target: ~$1,644
- TIKR Target Price: ~$2,240
- Earnings Date: July 15, 2026
Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free) >>>
What Happened?
ASML just did something that should not be possible: the company beat every major earnings benchmark analysts had set, raised its full-year guidance, and watched its stock fall anyway. Q1 2026 came in at around $10 billion in revenue with a 53% gross margin, and management lifted its 2026 outlook to a range of around $42 to $47 billion, implying up to 22% growth over last year. The stock briefly touched its 52-week high of $1,547 on the news, then gave it all back.
The culprit is the MATCH Act, a bipartisan U.S. bill that would ban exports of ASML’s less advanced DUV lithography machines to China. DUV, or deep ultraviolet, refers to an older generation of chip-making equipment that ASML has still been permitted to sell into China even as its more advanced EUV machines have been restricted since 2019. The MATCH Act closes that remaining door, and it specifically names ASML in its text, which is about as direct a legislative target as you will see.
China accounted for 33% of ASML’s total revenue in 2025, and the company had already guided investors to expect that to drop to around 20% in 2026 as the pre-buying cycle for DUV equipment wound down. But that guidance was set before the MATCH Act existed. If the bill passes, the 20% figure could shrink further, and the servicing revenue ASML earns on equipment already installed in China would be at risk too.
The bill still has to clear both chambers of Congress and receive a presidential signature. It also includes a 150-day window for the Netherlands and Japan to demonstrate their own tightening of export controls before the U.S. acts unilaterally. That diplomatic track has historically mattered. But investors are not waiting around to find out how it resolves.
See historical and forward estimates for ASML stock (It’s free) →
ASML Stock Financials
The financial trajectory here is genuinely impressive. Revenue has grown from around $22 billion in 2021 to around $38 billion in 2025, and operating margins have expanded from around 31% to nearly 35% over the same period. That combination of top-line growth and margin expansion is what a compounding business looks like over time, and it explains why long-term shareholders have been richly rewarded.
What makes ASML structurally different from most semiconductor companies is that it does not just sell machines. Every EUV system it ships requires ongoing calibration, software updates, spare parts, and field support. That installed-base management business generated nearly $3 billion in Q1 2026 alone, and it continues to grow as more machines enter service globally. It is one of the more durable recurring revenue streams in all of technology, and it is a big part of why margins hold up even when new system sales fluctuate.
The competitive context here is straightforward: there is no competition. ASML is the only company in the world capable of manufacturing EUV lithography machines, the equipment that leading chipmakers like TSMC, Samsung, and Intel use to produce the most advanced semiconductors.
That monopoly position is the result of decades of investment and an extraordinarily complex supply chain. Bernstein forecasts ASML will deliver around 44 EUV machines to memory chip manufacturers alone by 2028, roughly double the 2025 figure, as AI-driven demand for advanced chips continues to accelerate.
Wall Street’s Take on ASML Stock
The analyst community broadly agrees that ASML’s long-term thesis is intact. The street mean target sits around $1,644, roughly 13% above current levels, though that number was set largely before the MATCH Act became the dominant conversation.
The more interesting data point is the spread: analysts at Jefferies acknowledged the earnings beat but cautioned that, while estimates may drift higher toward the top of the new guidance range, the valuation multiple could gradually compress, limiting how much of that fundamental improvement actually shows up in the stock price.
That is the tension right now. This is not a company with a broken business. It has a $38.8 billion backlog, an around $14 billion buyback program underway, and a dividend that management just raised by 17%.
The question is whether a stock trading at nearly 48x trailing earnings can sustain that multiple while one of its largest markets is actively shrinking. The bulls say yes, because there is no replacement for ASML anywhere on the planet. The bears say the multiple needs to come down regardless of how good the business is.
What Does the Valuation Model Say?
TIKR’s valuation model targets around $2,240 for ASML, built on roughly 16% annual revenue growth through 2028, operating margins expanding toward 40%, and an exit P/E of around 34x. That multiple is consistent with where ASML has traded historically, reflecting the market’s willingness to pay a premium for a business with no real competitive alternative. Based on the current price, that implies an approximately 51% total return over roughly 2.7 years, or about 17% annualized.
What Has to Go Right:
- EUV demand keeps compounding. The AI chip buildout requires increasingly advanced lithography, and ASML is the only supplier. If TSMC, Samsung, and Intel continue expanding capacity at the pace of current capex plans, ASML’s order book stays full well into the decade.
- The MATCH Act stalls or gets watered down. The bill is still working through Congress, and the 150-day diplomatic window gives the Netherlands time to engage. If DUV exports to China continue even at reduced levels, the revenue impact stays within the current guidance range.
- Margin expansion continues. The move toward 40% operating margins is not a heroic assumption given the trajectory, but it requires the installed-base business to keep growing and the mix of high-margin EUV systems to remain favorable.
What Could Go Wrong:
- The MATCH Act passes in full. A complete ban on DUV exports to China, combined with restrictions on servicing installed equipment, would pressure revenue and likely force a guidance reset.
- The valuation multiple compresses. At nearly 48x trailing earnings, ASML is priced for continued execution. Any wobble in order timing or margin delivery gives the market a reason to de-rate, and Jefferies flagged this risk directly after the Q1 print.
- The AI capex cycle pauses. ASML’s growth assumptions depend heavily on chipmakers continuing to invest aggressively in advanced node capacity. If hyperscaler spending cools, order intake softens before the backlog provides much of a buffer.
Should You Invest in ASML?
The fundamental case for ASML has not changed. It is a monopoly in the most critical piece of equipment in the entire semiconductor supply chain, growing revenue at a double-digit pace, and returning capital to shareholders at an accelerating rate. None of that is in question.
What is in question is the price you are paying for it. At around $1,450, with real legislative risk hanging over a meaningful portion of its revenue base and a valuation multiple near the high end of its historical range, this is not a straightforward call in either direction. Add ASML to your TIKR watchlist, follow the progress of the MATCH Act through Congress, and watch how management frames China exposure on the July 15 earnings call. The long-term thesis is compelling. The near-term setup requires more patience than the recent price action might suggest.
TIKR gives you the tools to track it all in one place. Start your own analysis of ASML alongside every other stock on your radar with a free TIKR account.
Access Professional Tools to Analyze HLT stock on TIKR for Free →
